Original Publication Date: 1 February, 2015
Publication / Source: International Journal of Endocrine Oncology
Authors: Sujata Narayanan & Pamela L Kunz
Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms that have varying degrees of responsiveness to systemic and targeted therapies. With recent advances in therapeutics, a number of biologic therapies have been incorporated into the management of NETs.